| Primary |
| Sepsis |
25.0% |
| Erythema Multiforme |
16.7% |
| Polyuria |
16.7% |
| Pseudomembranous Colitis |
16.7% |
| Coronary Artery Disease |
8.3% |
| Electrolyte Substitution Therapy |
8.3% |
| Mitral Valve Replacement |
8.3% |
|
| Platelet Count Decreased |
100.0% |
|
| Secondary |
| Wound Complication |
12.6% |
| Rash |
8.9% |
| Constipation |
8.4% |
| Infection |
7.9% |
| Cerebral Infarction |
6.8% |
| Convulsion Prophylaxis |
6.3% |
| Hypertension |
5.3% |
| Eczema |
4.2% |
| Osteoarthritis |
4.2% |
| Pruritus |
4.2% |
| Fluid Replacement |
3.7% |
| Gastritis |
3.7% |
| Sputum Retention |
3.7% |
| Acute Coronary Syndrome |
3.2% |
| Insomnia |
3.2% |
| Type 2 Diabetes Mellitus |
3.2% |
| Asthma |
2.6% |
| Hepatic Function Abnormal |
2.6% |
| Neurogenic Bladder |
2.6% |
| Pyrexia |
2.6% |
|
| Sepsis |
27.3% |
| Myocardial Ischaemia |
18.2% |
| Stevens-johnson Syndrome |
18.2% |
| Acute Myocardial Infarction |
9.1% |
| Pyoderma |
9.1% |
| Tinea Infection |
9.1% |
| Ventricular Fibrillation |
9.1% |
|
| Concomitant |
| Prophylaxis |
17.0% |
| Colorectal Cancer |
9.7% |
| Constipation |
7.4% |
| Stomatitis |
6.7% |
| Insomnia |
6.3% |
| Product Used For Unknown Indication |
5.9% |
| Rash |
5.6% |
| Rheumatoid Arthritis |
5.5% |
| Behcet's Syndrome |
5.2% |
| Hypertension |
4.3% |
| Eczema |
3.8% |
| Gastritis |
3.8% |
| Chronic Hepatitis C |
3.0% |
| Pain |
2.5% |
| Cancer Pain |
2.5% |
| Ovarian Cancer Recurrent |
2.4% |
| Interstitial Lung Disease |
2.2% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.2% |
| Pyrexia |
2.1% |
| Diabetes Mellitus |
2.0% |
|
| Vomiting |
10.3% |
| Rash |
7.1% |
| White Blood Cell Count Decreased |
7.1% |
| Dermatitis Acneiform |
6.3% |
| Stomatitis |
6.3% |
| Malaise |
5.6% |
| Pulmonary Embolism |
5.6% |
| Pyrexia |
5.6% |
| Death |
4.8% |
| Interstitial Lung Disease |
4.8% |
| Subileus |
4.8% |
| Colorectal Cancer |
4.0% |
| Dry Skin |
4.0% |
| Lipase Increased |
4.0% |
| Sepsis |
4.0% |
| Diabetes Mellitus |
3.2% |
| Musculoskeletal Pain |
3.2% |
| Renal Impairment |
3.2% |
| Respiratory Failure |
3.2% |
| Thoracic Vertebral Fracture |
3.2% |
|
